Literature DB >> 12411968

Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity.

J J Wyndaele1, S A Van Dromme.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411968     DOI: 10.1038/sj.sc.3101318

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


× No keyword cloud information.
  32 in total

Review 1.  [Botulinum toxin in urology. Indications and results].

Authors:  B Schurch; A Reitz
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

Review 2.  Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults.

Authors:  Douglas G Tincello
Journal:  World J Urol       Date:  2011-10-15       Impact factor: 4.226

Review 3.  Autonomic side effects of Botulinum toxin Type B intravesical injections: report of 4 cases and review of the literature.

Authors:  M Ghei; B H Maraj; S Nathan; J Malone-Lee; R Miller
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers.

Authors: 
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

Review 5.  [Botulinum toxin for the treatment of neurogenic detrusor hyperactivity. Consensus paper on use for neurogenic bladder dysfunction].

Authors:  K-D Sievert; J Bremer; H Burgdörfer; B Domurath; C Hampel; J Kutzenberger; C Seif; M Stöhrer; B Wefer; J Pannek
Journal:  Urologe A       Date:  2007-03       Impact factor: 0.639

6.  [Seven years of botulinum toxin type A in the treatment of neurogenic detrusor hyperactivity].

Authors:  M Stöhrer; A Wolff; G Kramer; R Steiner; D Löchner-Ernst; D Leuth; U Steude; H Rübben
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

Review 7.  Efficacy and safety of botulinum toxin A intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic review.

Authors:  Irina Soljanik
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

Review 8.  Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.

Authors:  Todd A Linsenmeyer
Journal:  J Spinal Cord Med       Date:  2013-09       Impact factor: 1.985

9.  Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.

Authors:  Gael J Yonnet; Anette S Fjeldstad; Noel G Carlson; John W Rose
Journal:  Int J MS Care       Date:  2013

10.  Biomaterials in urinary incontinence and treatment of their complications.

Authors:  Philippa Sangster; Roland Morley
Journal:  Indian J Urol       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.